common.study.topics.clinical

Testing Treatment for Breast Cancer

common.study.values.description

“Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis”

The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic therapy.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Radiation - Stereotactic Body Radiotherapy

Five fraction SBRT (or two fraction in case of spine) to any sites of breast cancer oligometastasis using robotic radio surgery or linear accelerator based SBRT

participant.views.study.view.additional

participant.views.study.view.scientific-title

Stereotactic Body Radiotherapy (SBRT) for the Treatment of OligoMetastasis in Breast Cancer Patients (STOMP): A Prospective Feasibility Trial

common.study.values.clinical-trial-id

NCT03295916

participant.views.study.view.id

1aKDrb